REGULATED PRESS RELEASE published on 09/20/2024 at 08:00, 1 year 5 months ago MEDESIS PHARMA : Résultats encourageants de la première phase de l’essai clinique de phase 2a pour le traitement de la maladie d’Alzheimer avec le NanoLIthium Résultats encourageants de l'étude clinique de phase 2a pour le NanoLithium dans le traitement de la maladie d'Alzheimer. Premiers résultats positifs démontrant bonne tolérance et efficacité Nanolithium Essai Clinique Sécurité Efficacité Maladie D'Alzheimer
PRESS RELEASE published on 09/20/2024 at 08:00, 1 year 5 months ago Current Performance Update AgroGeneration provides an update on the impact of severe drought in Ukraine on its 2024 harvesting campaign, leading to significant production reductions and lower crop quality, affecting financial outlook Financial Outlook AgroGeneration Ukraine Harvesting Campaign Severe Drought
PRESS RELEASE published on 09/20/2024 at 08:00, 1 year 5 months ago Point sur la performance actuelle AgroGeneration, producteur de céréales et d'oléagineux basé en Ukraine, fait le point sur la campagne de récolte 2024, les prix des cultures, les perspectives financières et l'impact de la guerre en Ukraine AgroGeneration Ukraine Guerre Céréales Oléagineux
PRESS RELEASE published on 09/20/2024 at 07:30, 1 year 5 months ago XTPL with PLN 5.6 million of commercial sales in H1 2024 and progress on industrial projects - press release XTPL reports PLN 5.6 million sales in H1 2024, advances in industrial projects. Company aims for PLN 100 million sales by 2026 under the 2023-2026 Strategy XTPL H1 2024 Industrial Projects 2023-2026 Strategy PLN 5.6 Million
PRESS RELEASE published on 09/20/2024 at 07:30, 1 year 5 months ago Informations privilégiées / Autres communiqués Sensorion annonce de nouvelles données cliniques positives lors du Congrès Mondial d'Audiologie à Paris concernant les programmes de thérapie génique et de petite molécule Thérapie Génique Sensorion Données Cliniques Petite Molécule Congrès Mondial D'Audiologie
PRESS RELEASE published on 09/20/2024 at 07:30, 1 year 5 months ago Technip Energies et KBR sélectionnés pour un projet majeur de GNL par Lake Charles LNG Technip Energies et KBR sélectionnés par Lake Charles LNG pour un projet majeur de GNL aux États-Unis; contrat inclut la construction d'une installation d'exportation de GNL de 16,45 Mtpa Technip Energies Lake Charles LNG KBR Projet Majeur Construction GNL
PRESS RELEASE published on 09/20/2024 at 07:30, 1 year 5 months ago Inside Information / Other news releases Sensorion announces positive clinical data on gene therapy and small molecule programs at World Congress of Audiology, Paris. Details by key medical professionals Clinical Data Gene Therapy Sensorion World Congress Of Audiology Small Molecule
PRESS RELEASE published on 09/20/2024 at 07:30, 1 year 5 months ago Technip Energies and KBR selected for a major LNG project by Lake Charles LNG Technip Energies and KBR selected for a major LNG project by Lake Charles LNG, converting import terminal to export terminal, enhancing energy supply and global distribution Energy Supply Technip Energies Lake Charles LNG KBR LNG Project
PRESS RELEASE published on 09/20/2024 at 07:00, 1 year 5 months ago Mister Spex SE: Extraordinary General Meeting adopts all resolutions as proposed by the Company’s Boards Mister Spex SE's Extraordinary General Meeting approves resolutions focusing on streamlining governance, reducing Supervisory Board, and confirming previous decisions Shareholders Governance Mister Spex SE Extraordinary General Meeting Resolutions
PRESS RELEASE published on 09/20/2024 at 06:55, 1 year 5 months ago HUBER+SUHNER hosts second Capital Market Day HUBER+SUHNER hosts second Capital Market Day at headquarters in Herisau, Switzerland, offering insights into business model, strategy, and sustainability goals Innovation Sustainability Goals HUBER+SUHNER Business Model Capital Market Day
Published on 02/22/2026 at 23:45, 6 hours 18 minutes ago Barton Distributes $640,000 in JMEI Tax Credits
Published on 02/21/2026 at 00:45, 2 days 5 hours ago Bocana Resources Corp. Extends Letter of Intent on Arizona Mining Claims for Additional Bulk Testing and Assay Review
Published on 02/21/2026 at 00:30, 2 days 5 hours ago Redwood AI Corp. Announces Engagement for IR Services
Published on 02/20/2026 at 23:00, 2 days 7 hours ago Infinico Metals Corp. Announces Effective Date for 15-for-1 Common Share Consolidation
Published on 02/23/2026 at 03:26, 2 hours 36 minutes ago AGTech to Help Build One-Stop Trading Services Platform as Hong Kong Gold Exchange Opens for the Year of the Horse
Published on 02/22/2026 at 12:19, 17 hours 43 minutes ago Elmos Semiconductor SE: Generational change initiated in the Supervisory Board
Published on 02/22/2026 at 10:09, 19 hours 53 minutes ago Turkiye Garanti Bankasi A.S.: Regarding the Sale of Non-Performing Loans Portfolio
Published on 02/21/2026 at 12:00, 1 day 18 hours ago Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026
Published on 02/21/2026 at 12:00, 1 day 18 hours ago Abivax présente, au Congrès de l’ECCO 2026, les premières preuves d’une activité antifibrotique d'obefazimod, ainsi que de nouvelles analyses de son efficacité et de sécurité dans les MICI
Published on 02/20/2026 at 19:29, 2 days 10 hours ago SFPI GROUP: bilan du contrat de liquidité S2 S025
